Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02152956
Title Safety Study of MGD006 in Relapsed/Refractory Acute Myeloid Leukemia (AML) or Intermediate-2/High Risk MDS
Acronym VOYAGE
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors MacroGenics
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | ITA | ISR | GBR | FRA | ESP | DEU


No variant requirements are available.